Late presentation of glycogen storage disease types Ia and III in children with short stature and hepatomegaly

2018 ◽  
Vol 31 (4) ◽  
pp. 473-478 ◽  
Author(s):  
David Quackenbush ◽  
Justin Devito ◽  
Luigi Garibaldi ◽  
Melissa Buryk

AbstractBackground:Glycogen storage diseases (GSDs) are a collection of disorders related to glycogen synthesis or degradation that classically present in infancy with hypoglycemia, failure to thrive and hepatomegaly; however, their phenotype can vary significantly.Case presentation:We present the cases of two children, 5 years old and 3.5 years old, who were referred to endocrinology for short stature. They were ultimately found to have hepatomegaly, fasting hypoglycemia, mild elevation of transaminases and ketosis. Laboratory and genetic studies were consistent with double heterozygosity for GSDs Ia and III, with one novel mutation discovered in each patient. Nightly, both children were treated with cornstarch, which resulted in resolution of laboratory abnormalities and improvement in their growth velocity. These cases are unusual in that GSD was diagnosed relatively late in life in patients with no previous history of severe hypoglycemia.Conclusions:They highlight the importance of considering glycogen storage disease in a child presenting with short stature, as it is a treatable disease that can be diagnosed non-invasively with genetic testing.

2020 ◽  
Vol 10 (01) ◽  
pp. e45-e47
Author(s):  
Nida Mirza ◽  
Smita Malhotra ◽  
Anupam Sibal

AbstractGlycogen storage diseases are a group of heterogeneous metabolic disorders that result from a defect in enzymatic pathway of either glycogen synthesis or glycogen degradation. Here we are reporting a case of glycogen storage diseases type 1 with renal stone as initial manifestation of disease at 2 months of age. There were case reports of recurrent renal calculi in older age group with this disease and considered to be arisen due to metabolic derangements. Although the exact mechanism of renal stones in glycogen storage disease is not clear, in this unique case occurrence of renal stones at 2 months of age suggests that the pathogenesis of renal calculi is probably multifactorial or a part of disease.


2018 ◽  
Vol 31 (3) ◽  
pp. 331-338 ◽  
Author(s):  
Chunyun Li ◽  
Lihua Huang ◽  
Lang Tian ◽  
Jia Chen ◽  
Shentang Li ◽  
...  

AbstractBackground:PHKG2gene mutation can lead to liver phosphorylase kinase (PhK) deficiency, which is related to glycogen storage disease type IX (GSD IX). GSD IXc due toPHKG2mutation is the second most common GSD IX.Methods:We identified a novel mutation (c.553C>T, p.Arg185X) inPHKG2in a Chinese family and verified it by next-generation and Sanger sequencing. The mutation spectrum of thePHKG2gene was summarized based on 25 GSD IXc patients withPHKG2mutations.Results:We found that missense mutation (39%) was the most common type of mutation, followed by nonsense mutation (23%). Mutations were more prevalent in Asian (12/25) and European (9/25) populations than in populations from elsewhere. The exons had more sites of mutation than the introns, and exons 3 and 6 were the most frequent sites of mutations.Conclusions:This study expands our knowledge of thePHKG2gene mutation spectrum, providing a molecular basis for GSD IXc.


PEDIATRICS ◽  
1970 ◽  
Vol 46 (6) ◽  
pp. 929-933
Author(s):  
Scott J. Boley ◽  
Michael I. Cohen ◽  
Marvin L. Gliedman

Portacaval shunt was successfully employed in the treatment of Type I glycogen storage disease. Severe hypoglycemia, acidosis, hyperlipidemia, and hyperuricemia were corrected and have not recurred although the child is on a regular diet without medication. Based upon our result and the limited experience of others, total portal venous diversion is recommended in early infancy in children with severe hypoglycemia before permanent cerebral damage has occurred.


1971 ◽  
Vol 40 (3) ◽  
pp. 261-269 ◽  
Author(s):  
P. D. Leathwood ◽  
Brenda E. Ryman

1. A vacuum skin-blistering technique has been successfully applied and the human epidermal tissue so obtained has been examined for glycogen content and some of the enzymes involved in glycogen metabolism. 2. Normal values for glycogen phosphorylase, acid α-glucosidase and amylo-1,6-glucosidase (debranching enzyme) in epidermis are reported. Glucose 6-phosphatase activity was not detected. 3. Examination of two patients with Type II glycogen storage disease (Pompe's Disease—lack of lysosomal acid α-glucosidase) revealed an absence of the acid α-glucosidase in their skin. 4. The enzymic lesion in Type V glycogen storage disease (McArdle's Disease—lack of muscle phosphorylase) was not reflected in the epidermal tissue of a patient and a normal level of the enzyme was observed.


1998 ◽  
Vol 11 (S1) ◽  
pp. S323-S324 ◽  
Author(s):  
Pascale Trioche ◽  
Philippe Labrune ◽  
Michel Odièvre ◽  
Michelle Hedchouel ◽  
Jean-François Deleuze

2020 ◽  
Vol 54 (4) ◽  
Author(s):  
Sylvia C. Estrada

Glycogen storage disease (GSD) type IXa, due to a deficiency of hepatic phosphorylase b kinase, results in liver enlargement, growth retardation and fasting ketosis. Many are asymptomatic and do not require treatment. This is the first documented GSD IXa in a Filipino boy evaluated for short stature.


Sign in / Sign up

Export Citation Format

Share Document